Erlotinib 150Mg Suppliers, Dealers, Exporters, Wholesalers, delhi-India by Medivac international, Erlotinib hydrochloride (trade name Tarceva) is a drug used to treat non-small cell lung cancer (NSCLC), pancreatic cancer and several other types of cancer. It is a receptor tyrosine kinase inhibitor, which acts on the epidermal growth factor receptor (EGFR). Erlocip 150Mg Erlotinib 150 mg Exporter, Distributor, Supplier, Trading Company, Delhi, India.The offered medicines contain Erlotinib and belong to a class of medications called kinase inhibitors. These drugs are widely used to treat non-small cell lung, pancreatic and several other types of cancers. Erlocip is used for the treatment of non-small cell lung cancer. Erlocip is used in combination with gemcitabine for the treatment of pancreatic cancer that has spread to nearby tissues or to other parts of the body.
Erlotinib 150Mg Erlotinib Exporter, Distributor, Supplier, Trading Company, Delhi, India
Erlotinib has shown a survival benefit in the treatment of lung cancer in phase III trials. The SATURN (Sequential Tarceva in Unresectable NSCLC) study found that erlotinib added to chemotherapy improved overall survival by 19%, and improved progression-free survival (PFS) by 29%, when compared to chemotherapy alone
Erlocip is a prescription Drug and should be used under Proper Medical Guidance and Advice. Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug. Erlotinib 150Mg
Side effects of Erlotinib 150 mg Tablets
- Loss of appetite
- Rarely, interstitial pneumonitis
- Rarely, ingrown hairs, such as eyelashes
- It has also been suggested that erlotinib can cause hearing loss.
- Partial hair loss
Description For Anti-cancer- Erlotinib 150Mg Tablets
Erlotinib 150Mg bound to ErbB1 at 2.6A resolution; surface colour indicates hydrophobicity. As with other ATP competitive small molecule tyrosine kinase inhibitors, such as imatinib (Gleevec) in CML, patients rapidly develop resistance. In the case of erlotinib this typically occurs 8–12 months from the start of treatment. Over 50% of resistance is caused by a mutation in the ATP binding pocket of the EGFR kinase domain involving substitution of a small polar threonine residue with a large nonpolar methionine residue (T790M).
While proponents of the ‘gatekeeper’ mutation hypothesis suggest this mutation prevents the binding of erlotinib through steric hindrance, research suggests that T790M confers an increase in ATP binding affinity, thereby reducing the inhibitory efficacy of Erlotinib 150Mg .
Cost Price of Erlotinib 150Mg Tablets
Cost of Erlocip in Australia, Brazil, China, Canada, Eqypt, Europe, France, Germany, Hongkong, India, Iran, Italy, Mexico, Pakistan, Poland, Spain, Singapore, Thailand, Russia, Romania, UK, Middle East, UAE, Ukraine. Vietnam, Indonesia, Malaysia, South Korea, USA, London, Tajikistan, Uzbekistan, South Africa, China, Japan, Italy, Australia, New Zealand, Srilanka
Summary for Erlotinib 150Mg Tablets
Medivac international is the largest trading company for Erlocip 150Mg Erlotinib Exporter, Distributor, Supplier, Trading Company, Delhi, India and providing a best service to their customers